Complete Genomics Gets Trim Of Illumina’s DNA Tech IP Suit

Law360 (August 27, 2021, 7:55 PM EDT) — A California federal judge Friday trimmed Illumina’s lawsuit purportedly seeking to stop Complete Genomics’ “latest attempt at brazen infringement” of its DNA sequencing patents in a decade-long patent war, tossing a claim for literal infringement while declining to find a different Illumina patent invalid.

Illumina, a California-based publicly traded company with over $3 billion in revenue in 2018, has accused Complete Genomics Inc. of importing copycat sequencers that infringe three different patents. The rival companies have been fighting for at least a decade, including a suit currently pending in the same court.

The suit names CGI, its Chinese parent BGI Genomics…

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Read more here: Source link